PENICILLAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Penicillamine, and what generic alternatives are available?
Penicillamine is a drug marketed by Ani Pharms, Apotex, Breckenridge, Dr Reddys, Endo Operations, Granules, Invagen Pharms, Navinta Llc, Watson Labs Inc, Lupin Ltd, and Teva Pharms Usa. and is included in twelve NDAs.
The generic ingredient in PENICILLAMINE is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillamine
A generic version of PENICILLAMINE was approved as penicillamine by ANI PHARMS on May 7th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENICILLAMINE?
- What are the global sales for PENICILLAMINE?
- What is Average Wholesale Price for PENICILLAMINE?
Summary for PENICILLAMINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 17 |
| Patent Applications: | 3,416 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PENICILLAMINE |
| What excipients (inactive ingredients) are in PENICILLAMINE? | PENICILLAMINE excipients list |
| DailyMed Link: | PENICILLAMINE at DailyMed |
Recent Clinical Trials for PENICILLAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nanfang Hospital, Southern Medical University | Phase 2 |
| Alexion Pharmaceuticals | Phase 2 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Early Phase 1 |
Pharmacology for PENICILLAMINE
| Drug Class | Antirheumatic Agent |
Medical Subject Heading (MeSH) Categories for PENICILLAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PENICILLAMINE
US Patents and Regulatory Information for PENICILLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 209921-001 | May 7, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Invagen Pharms | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 213293-001 | Aug 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 211867-001 | Aug 4, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | PENICILLAMINE | penicillamine | TABLET;ORAL | 211497-001 | Feb 13, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Navinta Llc | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 214363-001 | Oct 8, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 213310-001 | Apr 28, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
